Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150349 | SCV000197459 | likely benign | not specified | 2018-10-31 | criteria provided, single submitter | clinical testing | The p.Pro1347Gln variant in COL11A2 is classified as likely benign because it ha s been identified in 0.3% (74/22572) of African chromosomes including 2 homozygo tes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org ). ACMG/AMP Criteria applied: BS1. |
Eurofins Ntd Llc |
RCV000150349 | SCV000704981 | likely benign | not specified | 2017-08-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764645 | SCV000895754 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 53; Autosomal dominant nonsyndromic hearing loss 13; Otospondylomegaepiphyseal dysplasia, autosomal recessive; Otospondylomegaepiphyseal dysplasia, autosomal dominant; Fibrochondrogenesis 2 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001560335 | SCV001782724 | likely benign | not provided | 2021-03-04 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001560335 | SCV002469993 | benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing |